The State of Texas Top Legal Officer Sues Acetaminophen Producers Regarding Autism Assertions

Judicial Case
The Texas Attorney General, a Trump ally seeking election to the United States Senate, accused pharmaceutical manufacturers of hiding safety concerns of Tylenol

The top legal official in Texas Paxton is suing the makers of acetaminophen, claiming the firms concealed alleged dangers that the medication posed to children's brain development.

The lawsuit comes a month after Donald Trump publicized an unproven link between taking Tylenol - also known as acetaminophen - while pregnant and autism spectrum disorder in children.

The attorney general is filing suit against Johnson & Johnson, which once produced the drug, the exclusive pain medication recommended for expectant mothers, and Kenvue, which currently produces it.

In a official comment, he said they "misled consumers by gaining financially from suffering and pushing pills regardless of the dangers."

The manufacturer states there is no credible evidence connecting Tylenol to autism spectrum disorder.

"These companies lied for decades, knowingly endangering numerous people to increase profits," the attorney general, from the Republican party, said.

The manufacturer said in a statement that it was "deeply concerned by the spread of false claims on the security of acetaminophen and the likely effects that could have on the welfare of US mothers and children."

On its website, the company also said it had "regularly reviewed the pertinent research and there is no credible data that demonstrates a verified association between taking acetaminophen and autism."

Associations representing physicians and health professionals concur.

The leading OB-GYN organization has declared acetaminophen - the primary component in Tylenol - is among limited choices for pregnant women to manage discomfort and fever, which can create major wellness concerns if ignored.

"In multiple decades of studies on the consumption of paracetamol in pregnancy, zero credible investigations has conclusively proven that the consumption of acetaminophen in any trimester of pregnancy results in brain development issues in offspring," the organization said.

The lawsuit cites latest statements from the previous government in asserting the medication is reportedly hazardous.

Last month, Trump caused concern from public health officials when he told expectant mothers to "struggle intensely" not to take acetaminophen when sick.

The FDA then released a statement that medical professionals should think about restricting the consumption of Tylenol, while also stating that "a causal relationship" between the medication and autism spectrum disorder in young ones has not been established.

The Health Department head Robert F Kennedy Jr, who manages the Food and Drug Administration, had promised in April to initiate "extensive scientific investigation" that would identify the origin of autism spectrum disorder in a short period.

But authorities cautioned that identifying a unique factor of autism spectrum disorder - considered by experts to be the consequence of a complicated interplay of genetic and surrounding conditions - would be difficult.

Autism spectrum disorder is a form of lifelong neurodivergence and impairment that affects how people encounter and relate to the environment, and is identified using doctors' observations.

In his legal document, Paxton - who supports Trump who is running for the Senate - asserts the manufacturer and Johnson & Johnson "intentionally overlooked and tried to quiet the research" around paracetamol and autism spectrum disorder.

The lawsuit seeks to make the firms "destroy any promotional materials" that asserts Tylenol is secure for expectant mothers.

The court case parallels the complaints of a assembly of guardians of young ones with autism and ADHD who filed suit against the producers of acetaminophen in two years ago.

The court rejected the lawsuit, saying research from the family's specialists was lacking definitive proof.

Dennis Caldwell
Dennis Caldwell

A tech enthusiast and digital strategist with a passion for exploring emerging technologies and sharing practical insights.